Suhail M Hadi
The Mount Sinai Medical Center, USA
Title: The use of 308-nm excimer laser for treatment of vitiligo
Biography
Biography: Suhail M Hadi
Abstract
Two hundred twenty one patches of stable vitiligo from ninety seven patients of different ethnic backgrounds were
treated with this modality of treatment. 54 were males and 43 were females. Mean age was 33.5 years. 30 lesions
were left untreated as controls. Patients were treated for 30 sessions or 75% repigmentation or more, whichever comes
first. Initial dose was 100mj/cm2 which is increasd by 1/2 MED(50 mj/cm2) until erythema developed treatment was
given twice per week. 50.6% of treated lesions showed 75% repigmentation or more, 64.3% of lesions showed 50%
repigmentation or more. Lesions on the face showed the best response with 77.6% of them achieved 75% repigmentation
or more and 81.3% had 50% repigmentation or more. Patients with skin phototype III-VI had the best results. None of the
control patches developed pigmentation. No significant side effects were encountered and none of the responding patients
lost their pigment during the two year follow up